XOMA Royalty (XOMA) Non Operating Income (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Non Operating Income came in at $4.8 million in Q1 2026, up 5110.53% year-on-year from $91353.5 in Q1 2025, and up 580.0% quarter-over-quarter from $700000.0 in Q4 2025.

XOMA Royalty (XOMA) Non Operating Income (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Non Operating Income across 16 years of filings, most recently posting $4.8 million for Q1 2026.

  • Non Operating Income for Q1 2026 came in at $4.8 million, up 5110.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.0 million (up 187.94% YoY), and the FY2025 annual result was $103000.0, down 98.51% from the prior year.
  • Non Operating Income came in at $4.8 million for Q1 2026 at XOMA Royalty, up from $700000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.8 million in Q2 2025 to a low of -$215000.0 in Q1 2022.
  • The 5-year median for Non Operating Income is $557000.0 (2023), against an average of $1.3 million.
  • Across the five-year window, Non Operating Income slumped 104.85% in 2025 and soared 5110.53% in 2026, its largest moves.
  • XOMA Royalty's Non Operating Income stood at $219000.0 in 2022, then jumped by 79.91% to $394000.0 in 2023, then soared by 159.14% to $1.0 million in 2024, then sank by 31.44% to $700000.0 in 2025, then jumped by 580.0% to $4.8 million in 2026.
  • The last three Non Operating Income figures came in at $4.8 million (Q1 2026), $700000.0 (Q4 2025), and $727000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 444,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - 9.35 Mn
10 XOMA Royalty 5.49 Mn -60.59 Mn - 4.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.76 Mn
Dec 31, 2025 700,000.00
Sep 30, 2025 727,000.00
Jun 30, 2025 7.82 Mn
Mar 31, 2025 -95,000.00
Dec 31, 2024 1.02 Mn
Sep 30, 2024 1.89 Mn
Jun 30, 2024 2.05 Mn
Mar 31, 2024 1.96 Mn
Dec 31, 2023 394,000.00
Sep 30, 2023 278,000.00
Jun 30, 2023 557,000.00
Mar 31, 2023 357,000.00
Dec 31, 2022 219,000.00
Sep 30, 2022 194,000.00
Jun 30, 2022 97,000.00
Mar 31, 2022 -215,000.00
Dec 31, 2021 -430,000.00
Sep 30, 2021 -1.09 Mn
Jun 30, 2021 1.30 Mn